BRIDGEBIO PHARMA, INC. (BBIO)
Clinical trial NCT04622046 updates: 1. collaborators added: Eidos Therapeutics, a BridgeBio company 2. collaborators removed: Eidos Therapeutics, a BridgeBio, Inc. Company
Clinical trial NCT04622046 updates: 1. collaborators added: Eidos Therapeutics, a BridgeBio company 2. collaborators removed: Eidos Therapeutics, a BridgeBio, Inc. Company
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical